Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Active drug: pimavanserin 17mg (2 strength tablets)
(D08969)
[1] Pimavanserin[1] Pimavanserin tartrate (D08969) 💬 [2] HTR2A,
HTR2C 💬
[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬
2PIMAVANSERIN
(D08969)
[1] Pimavanserin[1] Pimavanserin tartrate (D08969) 💬 [2] HTR2A,
HTR2C 💬
[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬
3Pimavanserin (ACP-103)
(D08969)
[1] Pimavanserin[1] Pimavanserin tartrate (D08969) 💬 [2] HTR2A,
HTR2C 💬
[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬
4Pimavanserin 34 mg
(D08969)
[1] Pimavanserin[1] Pimavanserin tartrate (D08969) 💬 [2] HTR2A,
HTR2C 💬
[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬
5PIMAVANSERIN TARTRATE
(D08969)
[1] Pimavanserin[1] Pimavanserin tartrate (D08969) 💬 [2] HTR2A,
HTR2C 💬
[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬
6Pimavanserin tartrate (ACP-103)
(D08969)
[1] Pimavanserin[1] Pimavanserin tartrate (D08969) 💬 [2] HTR2A,
HTR2C 💬
[6] Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬[1] 6 💬